Envveno Medical (NVNO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NVNO Annual Balance Sheets →
Tracking balance sheet results across Envveno Medical to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2.84
Short-term Investments, Total18.65
Cash & Short-term Investments20.00
Prepaid Expense And Other Assets Current0.60
Total Current Assets22.08
Equipment/Property/Plant Net0.08
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.56
Total Assets22.66
Liabilities
Accounts Payable and Other Accrued Liabilities, Current0.54
Accrued Liabilities And Other Liabilities0.55
Other Liabilities, Current0.79
Total Current Liabilities1.89
Total Long-term Debt0.00
Other liabilities, Noncurrent0.10
OperatingLeaseLiabilityNoncurrent0.21
Operating Lease Liability Current0.40
Total Liabilities1.99
Stockholders' Equity
Additional Paid In Capital Common Stock199.45
Retained Earnings / Accumulated Deficit-178.78
Other Equity0.00
Common Stockholder's Equity20.67
Total Stockholder's Equity20.67
Liabilities & Stockholder's Equity22.66
4 historic quarters locked

Sign in to unlock the full Envveno Medical balance sheet history.

About Envveno Medical Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 30, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-035452

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.